Quarterly report [Sections 13 or 15(d)]

License, Collaboration, and Other Arrangements - Takeda Collaboration Agreement and Takeda Revenue Share Agreement (Details)

v3.26.1
License, Collaboration, and Other Arrangements - Takeda Collaboration Agreement and Takeda Revenue Share Agreement (Details) - USD ($)
$ in Thousands
3 Months Ended 243 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Dec. 31, 2025
Acquisitions, Licensing and Other Arrangements        
Revenue from contracts with customers   $ 4,000    
Takeda Pharmaceutical Company Limited | Collaboration and Revenue share agreement        
Acquisitions, Licensing and Other Arrangements        
Revenue from contracts with customers $ 0 $ 4,000 $ 7,800  
Maximum remaining milestone payments 13,000   13,000  
Contract assets under Moderna collaboration 0   0 $ 0
Contract liabilities under Moderna collaboration 0   0 0
Capitalized contract costs $ 0   $ 0 $ 0